University of Iowa Health Care Medical Center Hematology and Medical Oncology

Topics

• Lymphoma Diagnosis and Treatment 408
• Prostate Cancer Treatment and Research 97
• Acute Myeloid Leukemia Research 88
• Cancer Immunotherapy and Biomarkers 85
• Hematopoietic Stem Cell Transplantation 79
• Multiple Myeloma Research and Treatments 61
• Chronic Lymphocytic Leukemia Research 50
• CAR-T cell therapy research 46
• Folate and B Vitamins Research 46
• Neuroendocrine Tumor Research Advances 39
• Cancer Genomics and Diagnostics 36
• Bladder and Urothelial Cancer Treatments 35

Most cited

1. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 1,863 citations · Umang Swami, Praveen Vikas

2. Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.

   The New England journal of medicine · 2022 · 1,350 citations · Umar Farooq

3. Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results.

   Nature medicine · 2023 · 572 citations · Michael Tomasson

4. Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.

   The New England journal of medicine · 2021 · 741 citations · Mohammed Milhem

5. Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma.

   Blood · 2023 · 409 citations · Umar Farooq

6. Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.

   The New England journal of medicine · 2023 · 409 citations ·